about
The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanismEvidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.CSF biomarkers for improved prognostic accuracy in acute CNS disease.Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.Sleep alterations in an environmental neurotoxin-induced model of parkinsonism.Sleep disorders, obesity, and aging: the role of orexinRespiration and autonomic regulation and orexin.White and gray matter abnormalities in narcolepsy with cataplexy.Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of NarcolepsyAerobic exercise and snoring in overweight children: a randomized controlled trialOrexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea.Emerging drugs for eating disorder treatment.Beyond sleep duration: distinct sleep dimensions are associated with obesity in children and adolescents.The hypocretin/orexin system: an increasingly important role in neuropsychiatry.Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects.Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteinsEffects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.Towards a common pathway for narcolepsy and rapid eye movement sleep behaviour disorder[Brazilian guidelines for the treatment of narcolepsy].Time perception in narcolepsy in comparison to patients with Parkinson's disease and healthy controls - an exploratory study.Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene.Polysomnographic findings in craniopharyngioma patients.Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach.Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal.Comparative analysis of multiple sleep latency tests (MSLT) parameters and occurrence of dreaming in patients with daytime sleepiness of narcoleptic and non-narcoleptic origin.
P2860
Q27024180-2B460C29-53C2-46E8-8004-E9325734DB30Q30485748-8DB72B2C-97E5-48C4-A834-7A0432914249Q33313220-2B418FDE-FF04-4DEA-B502-6218436AF06CQ34137244-FB55676C-55F9-469C-B4E9-A19BA33326DDQ34203614-8030D4EA-7BDD-4379-B704-EE27B5A4CAD8Q34451399-A97F3E5C-11D6-4E69-97E7-CD54105E9757Q35509945-0E52BB9C-8736-45A9-A6C1-829F4CD3C9AFQ35741839-61CA3255-0A31-42CA-99F1-2A198A398A05Q35884309-B38A19D3-744E-42A2-90BE-E22EB0F9860BQ35990819-5A724E98-1713-4858-AEB7-59ED01CE8B4EQ36018973-036A0C4B-5545-4128-94FD-A1075C1A613AQ36432739-F79A51AD-E3F5-4A8E-8236-4EF3CB0D7D07Q36458423-FBE33362-343E-488D-9D51-475DD45831D2Q37115947-A8A0BA43-2E02-4168-9D78-AF040B31E410Q38231949-44EBFD59-E050-4BD1-BA6E-A1A682D58585Q40224903-8866E7F1-1705-451A-A905-52CCC67796BDQ41026692-661D7543-0D5D-4059-AF3F-3D176471E643Q41825402-9510B1AD-2DA2-4F7E-A915-DF91CEEC68FFQ42233112-DB8964F3-B610-42E0-A625-2AB7FA3FD081Q42718691-D86ABC32-C5B9-47D5-819B-2695E6564D09Q42859562-F711369A-A7D5-4449-97C5-DE199044F274Q44683301-D8FDDAC1-AEA3-4A51-8EA4-C0895E8A2FDFQ46990442-33B23E3F-424B-49E8-8E89-EEE83C520120Q47680332-69D8F72D-1B7A-4BCB-BAA1-2310D66D98D3Q47839193-0C4AAE97-FEC2-4DB8-917D-4C325EBE3922Q48235911-3037FF3D-FE81-4124-B5F8-5E871F6A2D7AQ48321095-7DFC51B0-E437-41D2-82E5-973766B13851Q48361232-4C545289-F160-498D-A1D7-83A631B8CAD7Q48480428-EE1345DA-B6E1-48E3-80C5-6FEA8732047C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hypocretins (orexins) and sleep-wake disorders.
@ast
Hypocretins (orexins) and sleep-wake disorders.
@en
type
label
Hypocretins (orexins) and sleep-wake disorders.
@ast
Hypocretins (orexins) and sleep-wake disorders.
@en
prefLabel
Hypocretins (orexins) and sleep-wake disorders.
@ast
Hypocretins (orexins) and sleep-wake disorders.
@en
P1433
P1476
Hypocretins (orexins) and sleep-wake disorders.
@en
P2093
Christian R Baumann
Claudio L Bassetti
P304
P356
10.1016/S1474-4422(05)70196-4
P577
2005-10-01T00:00:00Z